{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:55:35Z","timestamp":1793192135707,"version":"4.5.0"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41569-024-01001-5","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T18:02:21Z","timestamp":1710784941000},"page":"556-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2905-3096","authenticated-orcid":false,"given":"Andrea","family":"Caporali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5321-8543","authenticated-orcid":false,"given":"Yvan","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5419-7935","authenticated-orcid":false,"given":"Rajesh","family":"Katare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-7738","authenticated-orcid":false,"given":"Fabio","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-8725","authenticated-orcid":false,"given":"Thierry","family":"Pedrazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-0702","authenticated-orcid":false,"given":"Costanza","family":"Emanueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"1001_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011104","volume":"8","author":"C Berry","year":"2019","unstructured":"Berry, C. et al. Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. J. Am. Heart Assoc. 8, e011104 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"1001_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.tcm.2017.03.002","volume":"27","author":"N Mihatov","year":"2017","unstructured":"Mihatov, N., Januzzi, J. L. Jr & Gaggin, H. K. Type 2 myocardial infarction due to supply-demand mismatch. Trends Cardiovasc. Med. 27, 408\u2013417 (2017).","journal-title":"Trends Cardiovasc. Med."},{"key":"1001_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). J. Am. Coll. Cardiol. 72, 2231\u20132264 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. 40, 237\u2013269 (2019).","journal-title":"Eur. Heart J."},{"key":"1001_CR5","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Circulation 138, e618\u2013e651 (2018).","journal-title":"Circulation"},{"key":"1001_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005375","volume":"12","author":"AN Nowbar","year":"2019","unstructured":"Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P. & Al-Lamee, R. Mortality from ischemic heart disease. Circ. Cardiovasc. Qual. Outcomes 12, e005375 (2019).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"1001_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","volume":"42","author":"J Taubel","year":"2021","unstructured":"Taubel, J. et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study. Eur. Heart J. 42, 178\u2013188 (2021).","journal-title":"Eur. Heart J."},{"key":"1001_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.003875","volume":"10","author":"O Vedin","year":"2017","unstructured":"Vedin, O. et al. Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study. Circ. Heart Fail. 10, e003875 (2017).","journal-title":"Circ. Heart Fail."},{"key":"1001_CR9","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","volume":"39","author":"SJ Shah","year":"2018","unstructured":"Shah, S. J. et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur. Heart J. 39, 3439\u20133450 (2018).","journal-title":"Eur. Heart J."},{"key":"1001_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021660","volume":"11","author":"JE John","year":"2022","unstructured":"John, J. E. et al. Coronary artery disease and heart failure with preserved ejection fraction: the ARIC study. J. Am. Heart Assoc. 11, e021660 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"1001_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.amjmed.2018.12.038","volume":"132","author":"IY Elgendy","year":"2019","unstructured":"Elgendy, I. Y. & Pepine, C. J. Heart failure with preserved ejection fraction: is ischemia due to coronary microvascular dysfunction a mechanistic factor? Am. J. Med. 132, 692\u2013697 (2019).","journal-title":"Am. J. Med."},{"key":"1001_CR12","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.118.313568","volume":"124","author":"IY Elgendy","year":"2019","unstructured":"Elgendy, I. Y., Mahtta, D. & Pepine, C. J. Medical therapy for heart failure caused by ischemic heart disease. Circ. Res. 124, 1520\u20131535 (2019).","journal-title":"Circ. Res."},{"key":"1001_CR13","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.08.2162","volume":"72","author":"TH Marwick","year":"2018","unstructured":"Marwick, T. H. Ejection fraction pros and cons: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 2360\u20132379 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","volume":"137","author":"AR Chapman","year":"2018","unstructured":"Chapman, A. R. et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 137, 1236\u20131245 (2018).","journal-title":"Circulation"},{"key":"1001_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.117.028991","volume":"136","author":"C Berry","year":"2017","unstructured":"Berry, C. Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease. Circulation 136, 437\u2013439 (2017).","journal-title":"Circulation"},{"key":"1001_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCRESAHA.121.319892","volume":"130","author":"HR Reynolds","year":"2022","unstructured":"Reynolds, H. R. et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circ. Res. 130, 529\u2013551 (2022).","journal-title":"Circ. Res."},{"key":"1001_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008868","volume":"7","author":"R Herscovici","year":"2018","unstructured":"Herscovici, R. et al. Ischemia and no obstructive coronary artery disease (INOCA): what is the risk? J. Am. Heart Assoc. 7, e008868 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"1001_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.116.025941","volume":"135","author":"MN Christiansen","year":"2017","unstructured":"Christiansen, M. N. et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 135, 1214\u20131223 (2017).","journal-title":"Circulation"},{"key":"1001_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002562","volume":"9","author":"K Srivaratharajah","year":"2016","unstructured":"Srivaratharajah, K. et al. Reduced myocardial flow in heart failure patients with preserved ejection fraction. Circ. Heart Fail. 9, e002562 (2016).","journal-title":"Circ. Heart Fail."},{"key":"1001_CR20","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao, C. W. et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145, e153\u2013e639 (2022).","journal-title":"Circulation"},{"key":"1001_CR21","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016 \u2014 40 for 195 countries and territories. Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"1001_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.hfc.2014.04.003","volume":"10","author":"C Andersson","year":"2014","unstructured":"Andersson, C. & Vasan, R. S. Epidemiology of heart failure with preserved ejection fraction. Heart Fail. Clin. 10, 377\u2013388 (2014).","journal-title":"Heart Fail. Clin."},{"key":"1001_CR23","first-page":"100302","volume":"30","author":"ND Ashokprabhu","year":"2023","unstructured":"Ashokprabhu, N. D., Quesada, O., Alvarez, Y. R. & Henry, T. D. INOCA\/ANOCA: mechanisms and novel treatments. Am. Heart J. 30, 100302 (2023).","journal-title":"Am. Heart J."},{"key":"1001_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/cells11071165","volume":"11","author":"L Schirone","year":"2022","unstructured":"Schirone, L. et al. An overview of the molecular mechanisms associated with myocardial ischemic injury: state of the art and translational perspectives. Cells 11, 1165 (2022).","journal-title":"Cells"},{"key":"1001_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/HCG.0000000000000062","volume":"13","author":"S Das","year":"2020","unstructured":"Das, S. et al. Noncoding RNAs in cardiovascular disease: current knowledge, tools and technologies for investigation, and future directions: a scientific statement from the American Heart Association. Circ. Genom. Precis. Med. 13, e000062 (2020).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1001_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41569-022-00680-2","volume":"19","author":"D Santovito","year":"2022","unstructured":"Santovito, D. & Weber, C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat. Rev. Cardiol. 19, 620\u2013638 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1001_CR27","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M. & Bauersachs, J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur. Heart J. 43, 2549\u20132561 (2022).","journal-title":"Eur. Heart J."},{"key":"1001_CR28","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.ymthe.2021.03.004","volume":"29","author":"Y Yan","year":"2021","unstructured":"Yan, Y. et al. The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy. Mol. Ther. 29, 2253\u20132267 (2021).","journal-title":"Mol. Ther."},{"key":"1001_CR29","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/cvr\/cvaa008","volume":"116","author":"HL Spencer","year":"2020","unstructured":"Spencer, H. L. et al. The LINC00961 transcript and its encoded micropeptide, small regulatory polypeptide of amino acid response, regulate endothelial cell function. Cardiovasc. Res. 116, 1981\u20131994 (2020).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16, 421\u2013433 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"1001_CR31","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.18632\/aging.203965","volume":"14","author":"N Zhong","year":"2022","unstructured":"Zhong, N., Nong, X., Diao, J. & Yang, G. piRNA-6426 increases DNMT3B-mediated SOAT1 methylation and improves heart failure. Aging 14, 2678\u20132694 (2022).","journal-title":"Aging"},{"key":"1001_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41556-020-0576-y","volume":"22","author":"XQ Gao","year":"2020","unstructured":"Gao, X. Q. et al. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNA. Nat. Cell Biol. 22, 1319\u20131331 (2020).","journal-title":"Nat. Cell Biol."},{"key":"1001_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.hlc.2016.02.015","volume":"25","author":"KS Rajan","year":"2016","unstructured":"Rajan, K. S. et al. Abundant and altered expression of PIWI-interacting RNAs during cardiac hypertrophy. Heart Lung Circ. 25, 1013\u20131020 (2016).","journal-title":"Heart Lung Circ."},{"key":"1001_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00335-021-09927-8","volume":"33","author":"YH Sun","year":"2022","unstructured":"Sun, Y. H., Lee, B. & Li, X. Z. The birth of piRNAs: how mammalian piRNAs are produced, originated, and evolved. Mamm. Genome 33, 293\u2013311 (2022).","journal-title":"Mamm. Genome"},{"key":"1001_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tig.2018.11.005","volume":"35","author":"J Kufel","year":"2019","unstructured":"Kufel, J. & Grzechnik, P. Small nucleolar RNAs tell a different tale. Trends Genet. 35, 104\u2013117 (2019).","journal-title":"Trends Genet."},{"key":"1001_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.omtn.2022.09.011","volume":"30","author":"E van Ingen","year":"2022","unstructured":"van Ingen, E. et al. C\/D box snoRNA SNORD113-6 guides 2\u2032-O-methylation and protects against site-specific fragmentation of tRNALeu(TAA) in vascular remodeling. Mol. Ther. Nucleic Acids 30, 162\u2013172 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/nar\/gkq776","volume":"39","author":"M Brameier","year":"2011","unstructured":"Brameier, M., Herwig, A., Reinhardt, R., Walter, L. & Gruber, J. Human box C\/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res. 39, 675\u2013686 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1001_CR38","doi-asserted-by":"publisher","first-page":"102087","DOI":"10.1016\/j.omtn.2023.102087","volume":"35","author":"NP Jagielski","year":"2024","unstructured":"Jagielski, N. P., Rai, A. K., Rajan, K. S., Mangal, V. & Garikipati, V. N. S. A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond. Mol. Ther. Nucleic Acids 35, 102087 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-981-15-1671-9_20","volume":"1229","author":"N Valkov","year":"2020","unstructured":"Valkov, N. & Das, S. Y RNAs: biogenesis, function and implications for the cardiovascular system. Adv. Exp. Med. Biol. 1229, 327\u2013342 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1001_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.122.063759","volume":"148","author":"X Li","year":"2023","unstructured":"Li, X. et al. Extracellular vesicle-encapsulated adeno-associated viruses for therapeutic gene delivery to the heart. Circulation 148, 405\u2013425 (2023).","journal-title":"Circulation"},{"key":"1001_CR41","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.molcel.2023.09.016","volume":"83","author":"B Kuhle","year":"2023","unstructured":"Kuhle, B., Chen, Q. & Schimmel, P. tRNA renovatio: rebirth through fragmentation. Mol. Cell 83, 3953\u20133971 (2023).","journal-title":"Mol. Cell"},{"key":"1001_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep20850","volume":"6","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. tRNA-derived small non-coding RNAs in response to ischemia inhibit angiogenesis. Sci. Rep. 6, 20850 (2016).","journal-title":"Sci. Rep."},{"key":"1001_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biom8030054","volume":"8","author":"L Shen","year":"2018","unstructured":"Shen, L. et al. A novel class of tRNA-derived small non-coding RNAs respond to myocardial hypertrophy and contribute to intergenerational inheritance. Biomolecules 8, 54 (2018).","journal-title":"Biomolecules"},{"key":"1001_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","volume":"23","author":"T Nojima","year":"2022","unstructured":"Nojima, T. & Proudfoot, N. J. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat. Rev. Mol. Cell Biol. 23, 389\u2013406 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1001_CR45","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.chembiol.2016.09.011","volume":"23","author":"Y Li","year":"2016","unstructured":"Li, Y., Syed, J. & Sugiyama, H. RNA\u2013DNA triplex formation by long noncoding RNAs. Cell Chem. Biol. 23, 1325\u20131333 (2016).","journal-title":"Cell Chem. Biol."},{"key":"1001_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-019-0206-3","volume":"21","author":"C Niehrs","year":"2020","unstructured":"Niehrs, C. & Luke, B. Regulatory R-loops as facilitators of gene expression and genome stability. Nat. Rev. Mol. Cell Biol. 21, 167\u2013178 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1001_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.devcel.2019.07.013","volume":"50","author":"N Ritter","year":"2019","unstructured":"Ritter, N. et al. The lncRNA locus handsdown regulates cardiac gene programs and is essential for early mouse development. Dev. Cell 50, 644\u2013657.e8 (2019).","journal-title":"Dev. Cell"},{"key":"1001_CR48","doi-asserted-by":"publisher","first-page":"eabc9191","DOI":"10.1126\/sciadv.abc9191","volume":"7","author":"MM Balas","year":"2021","unstructured":"Balas, M. M. et al. Establishing RNA\u2013RNA interactions remodels lncRNA structure and promotes PRC2 activity. Sci. Adv. 7, eabc9191 (2021).","journal-title":"Sci. Adv."},{"key":"1001_CR49","doi-asserted-by":"publisher","first-page":"dev199628","DOI":"10.1242\/dev.199628","volume":"148","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. LncRNA HBL1 is required for genome-wide PRC2 occupancy and function in cardiogenesis from human pluripotent stem cells. Development 148, dev199628 (2021).","journal-title":"Development"},{"key":"1001_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006525","volume":"13","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. Long noncoding RNA ahit protects against cardiac hypertrophy through SUZ12 (suppressor of Zeste 12 protein homolog)-mediated downregulation of MEF2A (myocyte enhancer factor 2A). Circ. Heart Fail. 13, e006525 (2020).","journal-title":"Circ. Heart Fail."},{"key":"1001_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2010.09.001","volume":"143","author":"UA Orom","year":"2010","unstructured":"Orom, U. A. et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46\u201358 (2010).","journal-title":"Cell"},{"key":"1001_CR52","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.molcel.2019.08.015","volume":"76","author":"R Saldana-Meyer","year":"2019","unstructured":"Saldana-Meyer, R. et al. RNA interactions are essential for CTCF-mediated genome organization. Mol. Cell 76, 412\u2013422 (2019).","journal-title":"Mol. Cell"},{"key":"1001_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yjmcc.2015.09.016","volume":"89","author":"S Ounzain","year":"2015","unstructured":"Ounzain, S. et al. CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. J. Mol. Cell Cardiol. 89, 98\u2013112 (2015).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR54","doi-asserted-by":"publisher","first-page":"eaai9118","DOI":"10.1126\/scitranslmed.aai9118","volume":"9","author":"R Micheletti","year":"2017","unstructured":"Micheletti, R. et al. The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Sci. Transl. Med. 9, eaai9118 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1001_CR55","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cvr\/cvac191","volume":"119","author":"I Plaisance","year":"2022","unstructured":"Plaisance, I. et al. A transposable element into the human long noncoding RNA CARMEN is a switch for cardiac precursor cell specification. Cardiovasc. Res. 119, 1361\u20131376 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR56","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1080\/15476286.2021.1891393","volume":"18","author":"Z Ward","year":"2021","unstructured":"Ward, Z., Pearson, J., Schmeier, S., Cameron, V. & Pilbrow, A. Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease. RNA Biol. 18, 2055\u20132072 (2021).","journal-title":"RNA Biol."},{"key":"1001_CR57","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1242\/dev.128074","volume":"143","author":"SP Barrett","year":"2016","unstructured":"Barrett, S. P. & Salzman, J. Circular RNAs: analysis, expression and potential functions. Development 143, 1838\u20131847 (2016).","journal-title":"Development"},{"key":"1001_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 27, 626\u2013641 (2017).","journal-title":"Cell Res."},{"key":"1001_CR59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Exon\u2013intron circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 22, 256\u2013264 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1001_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.omtn.2019.05.031","volume":"17","author":"X Li","year":"2019","unstructured":"Li, X. et al. lncRNA H19 alleviated myocardial I\/RI via suppressing miR-877-3p\/Bcl-2-mediated mitochondrial apoptosis. Mol. Ther. Nucleic Acids 17, 297\u2013309 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41420-021-00467-3","volume":"7","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. Overexpression of circRNA SNRK targets miR-103-3p to reduce apoptosis and promote cardiac repair through GSK3\u03b2\/\u03b2-catenin pathway in rats with myocardial infarction. Cell Death Discov. 7, 84 (2021).","journal-title":"Cell Death Discov."},{"key":"1001_CR62","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang, S. et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation 139, 2857\u20132876 (2019).","journal-title":"Circulation"},{"key":"1001_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11777-7","volume":"10","author":"VNS Garikipati","year":"2019","unstructured":"Garikipati, V. N. S. et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS\/VEGF-A axis. Nat. Commun. 10, 4317 (2019).","journal-title":"Nat. Commun."},{"key":"1001_CR64","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarcon","year":"2015","unstructured":"Alarcon, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. N6-methyladenosine marks primary microRNAs for processing. Nature 519, 482\u2013485 (2015).","journal-title":"Nature"},{"key":"1001_CR65","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1161\/ATVBAHA.121.316180","volume":"41","author":"A Chamorro-Jorganes","year":"2021","unstructured":"Chamorro-Jorganes, A. et al. METTL3 regulates angiogenesis by modulating let-7e-5p and miRNA-18a-5p expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 41, e325\u2013e337 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1001_CR66","doi-asserted-by":"publisher","first-page":"908976","DOI":"10.3389\/fgene.2022.908976","volume":"13","author":"L Li","year":"2022","unstructured":"Li, L. et al. m6A methylation in cardiovascular diseases: from mechanisms to therapeutic potential. Front. Genet. 13, 908976 (2022).","journal-title":"Front. Genet."},{"key":"1001_CR67","doi-asserted-by":"publisher","first-page":"709299","DOI":"10.3389\/fcell.2021.709299","volume":"9","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. N6-methyladenosine modification opens a new chapter in circular RNA biology. Front. Cell Dev. Biol. 9, 709299 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1001_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2021.05.006","volume":"160","author":"WK Sweaad","year":"2021","unstructured":"Sweaad, W. K. et al. Relevance of N6-methyladenosine regulators for transcriptome: implications for development and the cardiovascular system. J. Mol. Cell Cardiol. 160, 56\u201370 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR69","doi-asserted-by":"publisher","first-page":"1063636","DOI":"10.3389\/fonc.2023.1063636","volume":"13","author":"VY Cusenza","year":"2023","unstructured":"Cusenza, V. Y., Tameni, A., Neri, A. & Frazzi, R. The lncRNA epigenetics: the significance of m6A and m5C lncRNA modifications in cancer. Front. Oncol. 13, 1063636 (2023).","journal-title":"Front. Oncol."},{"key":"1001_CR70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm.2015.4","volume":"17","author":"K Nishikura","year":"2016","unstructured":"Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83\u201396 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1001_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-021-00979-8","volume":"8","author":"GP Marceca","year":"2021","unstructured":"Marceca, G. P. et al. MiREDiBase, a manually curated database of validated and putative editing events in microRNAs. Sci. Data 8, 199 (2021).","journal-title":"Sci. Data"},{"key":"1001_CR72","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.omtn.2020.07.020","volume":"21","author":"R van der Kwast","year":"2020","unstructured":"van der Kwast, R. et al. Adenosine-to-inosine editing of vasoactive microRNAs alters their targetome and function in ischemia. Mol. Ther. Nucleic Acids 21, 932\u2013953 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR73","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1261\/rna.041533.113","volume":"19","author":"Q Wang","year":"2013","unstructured":"Wang, Q. et al. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding. RNA 19, 1525\u20131536 (2013).","journal-title":"RNA"},{"key":"1001_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00395-022-00940-9","volume":"117","author":"KE Kokot","year":"2022","unstructured":"Kokot, K. E. et al. Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs. Basic Res. Cardiol. 117, 32 (2022).","journal-title":"Basic Res. Cardiol."},{"key":"1001_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yjmcc.2021.07.005","volume":"160","author":"NI Vlachogiannis","year":"2021","unstructured":"Vlachogiannis, N. I. et al. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease. J. Mol. Cell Cardiol. 160, 111\u2013120 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR76","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1093\/nar\/gks071","volume":"40","author":"IV Novikova","year":"2012","unstructured":"Novikova, I. V., Hennelly, S. P. & Sanbonmatsu, K. Y. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res. 40, 5034\u20135051 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1001_CR77","doi-asserted-by":"publisher","first-page":"D79","DOI":"10.1093\/nar\/gkw835","volume":"45","author":"J Gong","year":"2017","unstructured":"Gong, J. et al. LNCediting: a database for functional effects of RNA editing in lncRNAs. Nucleic Acids Res. 45, D79\u2013D84 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1001_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020391","volume":"2","author":"A Athanasiadis","year":"2004","unstructured":"Athanasiadis, A., Rich, A. & Maas, S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2, e391 (2004).","journal-title":"PLoS Biol."},{"key":"1001_CR79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","volume":"14","author":"E Hergenreider","year":"2012","unstructured":"Hergenreider, E. et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14, 249\u2013256 (2012).","journal-title":"Nat. Cell Biol."},{"key":"1001_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9024","volume":"6","author":"A Caporali","year":"2015","unstructured":"Caporali, A. et al. p75NTR-dependent activation of NF-\u03baB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nat. Commun. 6, 8024 (2015).","journal-title":"Nat. Commun."},{"key":"1001_CR81","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1161\/ATVBAHA.119.312707","volume":"39","author":"YJ Chang","year":"2019","unstructured":"Chang, Y. J. et al. Extracellular microRNA-92a mediates endothelial cell\u2013macrophage communication. Arterioscler. Thromb. Vasc. Biol. 39, 2492\u20132504 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1001_CR82","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.120.317244","volume":"128","author":"J Li","year":"2021","unstructured":"Li, J. et al. Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling. Circ. Res. 128, e1\u2013e23 (2021).","journal-title":"Circ. Res."},{"key":"1001_CR83","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.116.310557","volume":"120","author":"P Mathiyalagan","year":"2017","unstructured":"Mathiyalagan, P. et al. Angiogenic mechanisms of human CD34+ stem cell exosomes in the repair of ischemic hindlimb. Circ. Res. 120, 1466\u20131476 (2017).","journal-title":"Circ. Res."},{"key":"1001_CR84","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.omtn.2021.04.014","volume":"24","author":"F Huang","year":"2021","unstructured":"Huang, F. et al. Exosomally derived Y RNA fragment alleviates hypertrophic cardiomyopathy in transgenic mice. Mol. Ther. Nucleic Acids 24, 951\u2013960 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR85","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen, D. K., Zhang, Q., Franklin, J. L. & Coffey, R. J. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 33, 667\u2013681 (2023).","journal-title":"Trends Cell Biol."},{"key":"1001_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154274","volume":"11","author":"C Emanueli","year":"2016","unstructured":"Emanueli, C. et al. Coronary artery-bypass-graft surgery increases the plasma concentration of exosomes carrying a cargo of cardiac microRNAs: an example of exosome trafficking out of the human heart with potential for cardiac biomarker discovery. PLoS ONE 11, e0154274 (2016).","journal-title":"PLoS ONE"},{"key":"1001_CR87","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.7150\/thno.33683","volume":"9","author":"D He","year":"2019","unstructured":"He, D. et al. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring. Theranostics 9, 4494\u20134507 (2019).","journal-title":"Theranostics"},{"key":"1001_CR88","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1084\/jem.20182313","volume":"216","author":"H Lee","year":"2019","unstructured":"Lee, H. et al. Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli. J. Exp. Med. 216, 2202\u20132220 (2019).","journal-title":"J. Exp. Med."},{"key":"1001_CR89","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-020-01737-0","volume":"11","author":"H Cheng","year":"2020","unstructured":"Cheng, H. et al. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis. Stem Cell Res. Ther. 11, 224 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"1001_CR90","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2337\/db17-1308","volume":"67","author":"DW Freeman","year":"2018","unstructured":"Freeman, D. W. et al. Altered extracellular vesicle concentration, cargo, and function in diabetes. Diabetes 67, 2377\u20132388 (2018).","journal-title":"Diabetes"},{"key":"1001_CR91","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nyas.14974","volume":"1523","author":"J Cable","year":"2023","unstructured":"Cable, J. et al. Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report. Ann. N. Y. Acad. Sci. 1523, 24\u201337 (2023).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1001_CR92","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/cvr\/cvz239","volume":"116","author":"S Ben-Aicha","year":"2020","unstructured":"Ben-Aicha, S. et al. High-density lipoprotein remodelled in hypercholesterolaemic blood induce epigenetically driven down-regulation of endothelial HIF-1\u03b1 expression in a preclinical animal model. Cardiovasc. Res. 116, 1288\u20131299 (2020).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR93","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","volume":"23","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nat. Cell Biol. 23, 1240\u20131254 (2021).","journal-title":"Nat. Cell Biol."},{"key":"1001_CR94","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen, D. K. et al. Reassessment of exosome composition. Cell 177, 428\u2013445 (2019).","journal-title":"Cell"},{"key":"1001_CR95","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.celrep.2019.01.009","volume":"27","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Transfer of functional cargo in exomeres. Cell Rep. 27, 940\u2013954 (2019).","journal-title":"Cell Rep."},{"key":"1001_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1001_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/cvr\/cvac031","volume":"119","author":"SM Davidson","year":"2023","unstructured":"Davidson, S. M. et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc. Res. 119, 45\u201363 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR98","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","volume":"120","author":"FAW Coumans","year":"2017","unstructured":"Coumans, F. A. W. et al. Methodological guidelines to study extracellular vesicles. Circ. Res. 120, 1632\u20131648 (2017).","journal-title":"Circ. Res."},{"key":"1001_CR99","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"1001_CR100","unstructured":"exRNA Atlas: data, tools & computable knowledge. https:\/\/exrna-atlas.org (US National Instiutes of Health, 2024)."},{"key":"1001_CR101","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2019.02.018","volume":"177","author":"OD Murillo","year":"2019","unstructured":"Murillo, O. D. et al. exRNA atlas analysis reveals distinct extracellular rna cargo types and their carriers present across human biofluids. Cell 177, 463\u2013477 (2019).","journal-title":"Cell"},{"key":"1001_CR102","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cels.2019.03.004","volume":"8","author":"J Rozowsky","year":"2019","unstructured":"Rozowsky, J. et al. exceRpt: a comprehensive analytic platform for extracellular RNA profiling. Cell Syst. 8, 352\u2013357 (2019).","journal-title":"Cell Syst."},{"key":"1001_CR103","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","volume":"15","author":"JE Fish","year":"2008","unstructured":"Fish, J. E. et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272\u2013284 (2008).","journal-title":"Dev. Cell"},{"key":"1001_CR104","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/pnas.0707493105","volume":"105","author":"TA Harris","year":"2008","unstructured":"Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T. & Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA 105, 1516\u20131521 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1001_CR105","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1161\/CIRCULATIONAHA.112.001357","volume":"128","author":"S Heymans","year":"2013","unstructured":"Heymans, S. et al. Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 128, 1420\u20131432 (2013).","journal-title":"Circulation"},{"key":"1001_CR106","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980\u2013984 (2008).","journal-title":"Nature"},{"key":"1001_CR107","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang, C. et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124, 2136\u20132146 (2014).","journal-title":"J. Clin. Invest."},{"key":"1001_CR108","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613\u2013618 (2007).","journal-title":"Nat. Med."},{"key":"1001_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14349-2","volume":"11","author":"A Foinquinos","year":"2020","unstructured":"Foinquinos, A. et al. Preclinical development of a miR-132 inhibitor for heart failure treatment. Nat. Commun. 11, 633 (2020).","journal-title":"Nat. Commun."},{"key":"1001_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2090","volume":"3","author":"A Ucar","year":"2012","unstructured":"Ucar, A. et al. The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 3, 1078 (2012).","journal-title":"Nat. Commun."},{"key":"1001_CR111","doi-asserted-by":"publisher","first-page":"592362","DOI":"10.3389\/fcvm.2021.592362","volume":"8","author":"Z Lei","year":"2021","unstructured":"Lei, Z. et al. miR-132\/212 impairs cardiomyocytes contractility in the failing heart by suppressing SERCA2a. Front. Cardiovasc. Med. 8, 592362 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1001_CR112","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","volume":"42","author":"S Batkai","year":"2021","unstructured":"Batkai, S. et al. CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure. Eur. Heart J. 42, 192\u2013201 (2021).","journal-title":"Eur. Heart J."},{"key":"1001_CR113","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm.2186","volume":"16","author":"S Anand","year":"2010","unstructured":"Anand, S. et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909\u2013914 (2010).","journal-title":"Nat. Med."},{"key":"1001_CR114","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvw235","volume":"113","author":"S Rawal","year":"2017","unstructured":"Rawal, S. et al. Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc. Res. 113, 90\u2013101 (2017).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ejhf.961","volume":"20","author":"S Masson","year":"2018","unstructured":"Masson, S. et al. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure. Eur. J. Heart Fail. 20, 78\u201385 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"1001_CR116","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.3390\/ijms23147514","volume":"23","author":"JP Huang","year":"2022","unstructured":"Huang, J. P. et al. Exosomal microRNAs miR-30d-5p and miR-126a-5p are associated with heart failure with preserved ejection fraction in STZ-induced type 1 diabetic rats. Int. J. Mol. Sci. 23, 7514 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1001_CR117","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710\u20131713 (2009).","journal-title":"Science"},{"key":"1001_CR118","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.113.001904","volume":"128","author":"R Hinkel","year":"2013","unstructured":"Hinkel, R. et al. Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model. Circulation 128, 1066\u20131075 (2013).","journal-title":"Circulation"},{"key":"1001_CR119","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/nat.2020.0871","volume":"30","author":"WT Abplanalp","year":"2020","unstructured":"Abplanalp, W. T. et al. Efficiency and target derepression of anti-miR-92a: results of a first in human study. Nucleic Acid Ther. 30, 335\u2013345 (2020).","journal-title":"Nucleic Acid Ther."},{"key":"1001_CR120","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCRESAHA.111.248880","volume":"109","author":"ER Porrello","year":"2011","unstructured":"Porrello, E. R. et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res. 109, 670\u2013679 (2011).","journal-title":"Circ. Res."},{"key":"1001_CR121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.omtn.2019.05.002","volume":"17","author":"M Besnier","year":"2019","unstructured":"Besnier, M. et al. miR-15a\/-16 inhibit angiogenesis by targeting the Tie2 coding sequence: therapeutic potential of a miR-15a\/16 decoy system in limb ischemia. Mol. Ther. Nucleic Acids 17, 49\u201362 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR122","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.111.300418","volume":"112","author":"G Spinetti","year":"2013","unstructured":"Spinetti, G. et al. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ. Res. 112, 335\u2013346 (2013).","journal-title":"Circ. Res."},{"key":"1001_CR123","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCRESAHA.117.305962","volume":"117","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ. Res. 117, 450\u2013459 (2015).","journal-title":"Circ. Res."},{"key":"1001_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03019-z","volume":"9","author":"W Huang","year":"2018","unstructured":"Huang, W. et al. Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nat. Commun. 9, 700 (2018).","journal-title":"Nat. Commun."},{"key":"1001_CR125","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCRESAHA.112.300658","volume":"112","author":"J Chen","year":"2013","unstructured":"Chen, J. et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ. Res. 112, 1557\u20131566 (2013).","journal-title":"Circ. Res."},{"key":"1001_CR126","doi-asserted-by":"publisher","first-page":"279ra238","DOI":"10.1126\/scitranslmed.3010841","volume":"7","author":"Y Tian","year":"2015","unstructured":"Tian, Y. et al. A microRNA\u2013Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci. Transl. Med. 7, 279ra238 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1001_CR127","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11739","volume":"492","author":"A Eulalio","year":"2012","unstructured":"Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376\u2013381 (2012).","journal-title":"Nature"},{"key":"1001_CR128","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia, K. et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569, 418\u2013422 (2019).","journal-title":"Nature"},{"key":"1001_CR129","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/eurheartj\/ehu180","volume":"36","author":"S Ounzain","year":"2015","unstructured":"Ounzain, S. et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur. Heart J. 36, 353\u2013368 (2015).","journal-title":"Eur. Heart J."},{"key":"1001_CR130","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/CIRCULATIONAHA.115.021019","volume":"133","author":"MD Ballantyne","year":"2016","unstructured":"Ballantyne, M. D. et al. Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation. Circulation 133, 2050\u20132065 (2016).","journal-title":"Circulation"},{"key":"1001_CR131","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/ATVBAHA.114.303240","volume":"34","author":"RD Bell","year":"2014","unstructured":"Bell, R. D. et al. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler. Thromb. Vasc. Biol. 34, 1249\u20131259 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1001_CR132","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.yjmcc.2019.03.012","volume":"129","author":"CR Martens","year":"2019","unstructured":"Martens, C. R., Bansal, S. S. & Accornero, F. Cardiovascular inflammation: RNA takes the lead. J. Mol. Cell Cardiol. 129, 247\u2013256 (2019).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR133","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijcard.2015.10.136","volume":"203","author":"M Zhang","year":"2016","unstructured":"Zhang, M., Gu, H., Xu, W. & Zhou, X. Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats. Int. J. Cardiol. 203, 214\u2013216 (2016).","journal-title":"Int. J. Cardiol."},{"key":"1001_CR134","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature13596","volume":"514","author":"P Han","year":"2014","unstructured":"Han, P. et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 514, 102\u2013106 (2014).","journal-title":"Nature"},{"key":"1001_CR135","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1161\/CIRCRESAHA.114.302476","volume":"114","author":"K Wang","year":"2014","unstructured":"Wang, K. et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ. Res. 114, 1377\u20131388 (2014).","journal-title":"Circ. Res."},{"key":"1001_CR136","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jacc.2018.04.085","volume":"72","author":"B Cai","year":"2018","unstructured":"Cai, B. et al. The long noncoding RNA CAREL controls cardiac regeneration. J. Am. Coll. Cardiol. 72, 534\u2013550 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR137","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.118.035832","volume":"139","author":"M Ponnusamy","year":"2019","unstructured":"Ponnusamy, M. et al. Long noncoding RNA CPR (cardiomyocyte proliferation regulator) regulates cardiomyocyte proliferation and cardiac repair. Circulation 139, 2668\u20132684 (2019).","journal-title":"Circulation"},{"key":"1001_CR138","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ymthe.2018.10.021","volume":"27","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Long non-coding RNA ECRAR triggers post-natal myocardial regeneration by activating ERK1\/2 signaling. Mol. Ther. 27, 29\u201345 (2019).","journal-title":"Mol. Ther."},{"key":"1001_CR139","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","volume":"121","author":"MT Piccoli","year":"2017","unstructured":"Piccoli, M. T. et al. Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ. Res. 121, 575\u2013583 (2017).","journal-title":"Circ. Res."},{"key":"1001_CR140","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/CIRCULATIONAHA.122.062601","volume":"148","author":"P Aghagolzadeh","year":"2023","unstructured":"Aghagolzadeh, P. et al. Assessment of the cardiac noncoding transcriptome by single-cell RNA sequencing identifies FIXER, a conserved profibrogenic long noncoding RNA. Circulation 148, 778\u2013797 (2023).","journal-title":"Circulation"},{"key":"1001_CR141","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","volume":"8","author":"Q Yuan","year":"2023","unstructured":"Yuan, Q. et al. CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes. Signal Transduct. Target. Ther. 8, 99 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1001_CR142","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1124\/dmd.121.000418","volume":"50","author":"F Alhamadani","year":"2022","unstructured":"Alhamadani, F. et al. Adverse drug reactions and toxicity of the food and drug administration-approved antisense oligonucleotide drugs. Drug Metab. Dispos. 50, 879\u2013887 (2022).","journal-title":"Drug Metab. Dispos."},{"key":"1001_CR143","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/17460441.2023.2236552","volume":"18","author":"O Khorkova","year":"2023","unstructured":"Khorkova, O. et al. Long non-coding RNA-targeting therapeutics: discovery and development update. Expert Opin. Drug Discov. 18, 1011\u20131029 (2023).","journal-title":"Expert Opin. Drug Discov."},{"key":"1001_CR144","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673\u2013694 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1001_CR145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-0771-8_1","volume":"2176","author":"KRQ Lim","year":"2020","unstructured":"Lim, K. R. Q. & Yokota, T. Invention and early history of gapmers. Methods Mol. Biol. 2176, 3\u201319 (2020).","journal-title":"Methods Mol. Biol."},{"key":"1001_CR146","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/nar\/gkab047","volume":"49","author":"G Vasquez","year":"2021","unstructured":"Vasquez, G. et al. Site-specific incorporation of 5\u2032-methyl DNA enhances the therapeutic profile of gapmer ASOs. Nucleic Acids Res. 49, 1828\u20131839 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1001_CR147","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","volume":"39","author":"D Li","year":"2018","unstructured":"Li, D., Mastaglia, F. L., Fletcher, S. & Wilton, S. D. Precision medicine through antisense oligonucleotide-mediated exon skipping. Trends Pharmacol. Sci. 39, 982\u2013994 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"1001_CR148","doi-asserted-by":"publisher","first-page":"562","DOI":"10.15252\/emmm.201505047","volume":"7","author":"M Gramlich","year":"2015","unstructured":"Gramlich, M. et al. Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Mol. Med. 7, 562\u2013576 (2015).","journal-title":"EMBO Mol. Med."},{"key":"1001_CR149","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cvr\/cvac191","volume":"119","author":"I Plaisance","year":"2023","unstructured":"Plaisance, I. et al. A transposable element into the human long noncoding RNA CARMEN is a switch for cardiac precursor cell specification. Cardiovasc. Res. 119, 1361\u20131376 (2023).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR150","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1101\/gad.270421.115","volume":"29","author":"MC Kramer","year":"2015","unstructured":"Kramer, M. C. et al. Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev. 29, 2168\u20132182 (2015).","journal-title":"Genes Dev."},{"key":"1001_CR151","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41589-019-0327-1","volume":"15","author":"XM Liu","year":"2019","unstructured":"Liu, X. M., Zhou, J., Mao, Y., Ji, Q. & Qian, S. B. Programmable RNA N6-methyladenosine editing by CRISPR\u2013Cas9 conjugates. Nat. Chem. Biol. 15, 865\u2013871 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1001_CR152","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/nat.2020.0866","volume":"31","author":"K Nose","year":"2021","unstructured":"Nose, K., Hidaka, K., Yano, T., Tomita, Y. & Fukuda, M. Short-chain guide RNA for site-directed A-to-I RNA editing. Nucleic Acid Ther. 31, 58\u201367 (2021).","journal-title":"Nucleic Acid Ther."},{"key":"1001_CR153","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41587-021-01171-4","volume":"40","author":"D Katrekar","year":"2022","unstructured":"Katrekar, D. et al. Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat. Biotechnol. 40, 938\u2013945 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1001_CR154","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/15476286.2021.1983288","volume":"18","author":"HM Khosravi","year":"2021","unstructured":"Khosravi, H. M. & Jantsch, M. F. Site-directed RNA editing: recent advances and open challenges. RNA Biol. 18, 41\u201350 (2021).","journal-title":"RNA Biol."},{"key":"1001_CR155","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCRESAHA.116.309819","volume":"120","author":"AJ Kanelidis","year":"2017","unstructured":"Kanelidis, A. J., Premer, C., Lopez, J., Balkan, W. & Hare, J. M. Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials. Circ. Res. 120, 1139\u20131150 (2017).","journal-title":"Circ. Res."},{"key":"1001_CR156","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0735-1097(03)00915-X","volume":"42","author":"G von Degenfeld","year":"2003","unstructured":"von Degenfeld, G. et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J. Am. Coll. Cardiol. 42, 1120\u20131128 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR157","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-0716-2707-5_11","volume":"2573","author":"SA Mavropoulos","year":"2022","unstructured":"Mavropoulos, S. A., Yamada, K. P., Sakata, T. & Ishikawa, K. Cardiac gene delivery in large animal models: antegrade techniques. Methods Mol. Biol. 2573, 147\u2013158 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1001_CR158","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","volume":"137","author":"L Gao","year":"2018","unstructured":"Gao, L. et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation 137, 1712\u20131730 (2018).","journal-title":"Circulation"},{"key":"1001_CR159","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1161\/01.CIR.0000153338.47507.83","volume":"111","author":"K Kikuchi","year":"2005","unstructured":"Kikuchi, K., McDonald, A. D., Sasano, T. & Donahue, J. K. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 111, 264\u2013270 (2005).","journal-title":"Circulation"},{"key":"1001_CR160","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.7150\/thno.34895","volume":"9","author":"JA Kopechek","year":"2019","unstructured":"Kopechek, J. A. et al. Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function. Theranostics 9, 7088\u20137098 (2019).","journal-title":"Theranostics"},{"key":"1001_CR161","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1021\/jacs.7b00528","volume":"139","author":"DE Clarke","year":"2017","unstructured":"Clarke, D. E., Pashuck, E. T., Bertazzo, S., Weaver, J. V. M. & Stevens, M. M. Self-healing, self-assembled beta-sheet peptide-poly(\u03b3-glutamic acid) hybrid hydrogels. J. Am. Chem. Soc. 139, 7250\u20137255 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"1001_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202959","volume":"12","author":"J Yuan","year":"2023","unstructured":"Yuan, J. et al. Microneedle patch loaded with exosomes containing microRNA-29b prevents cardiac fibrosis after myocardial infarction. Adv. Healthc. Mater. 12, e2202959 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"1001_CR163","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg, B. et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 387, 1178\u20131186 (2016).","journal-title":"Lancet"},{"key":"1001_CR164","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/humc.2017.070","volume":"28","author":"MG Katz","year":"2017","unstructured":"Katz, M. G., Fargnoli, A. S., Weber, T., Hajjar, R. J. & Bridges, C. R. Use of adeno-associated virus vector for cardiac gene delivery in large-animal surgical models of heart failure. Hum. Gene Ther. Clin. Dev. 28, 157\u2013164 (2017).","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"1001_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37774-5","volume":"14","author":"M Subramanian","year":"2023","unstructured":"Subramanian, M. et al. RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes. Nat. Commun. 14, 1970 (2023).","journal-title":"Nat. Commun."},{"key":"1001_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103867","volume":"9","author":"T Bozoglu","year":"2022","unstructured":"Bozoglu, T. et al. Endothelial retargeting of AAV9 in vivo. Adv. Sci. 9, e2103867 (2022).","journal-title":"Adv. Sci."},{"key":"1001_CR167","doi-asserted-by":"publisher","first-page":"952755","DOI":"10.3389\/fcvm.2022.952755","volume":"9","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Zhan, Q., Huang, B., Wang, Y. & Wang, X. AAV-mediated gene therapy: advancing cardiovascular disease treatment. Front. Cardiovasc. Med. 9, 952755 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1001_CR168","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"1001_CR169","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41420-022-00909-6","volume":"8","author":"R Yue","year":"2022","unstructured":"Yue, R. et al. Mesenchymal stem cell-derived exosomal microRNA-182-5p alleviates myocardial ischemia\/reperfusion injury by targeting GSDMD in mice. Cell Death Discov. 8, 202 (2022).","journal-title":"Cell Death Discov."},{"key":"1001_CR170","doi-asserted-by":"publisher","DOI":"10.3791\/65553","author":"R Aggarwal","year":"2023","unstructured":"Aggarwal, R. et al. Surgical porcine model of chronic myocardial ischemia treated by exosome-laden collagen patch and off-pump coronary artery bypass graft. J. Vis. Exp. https:\/\/doi.org\/10.3791\/65553 (2023).","journal-title":"J. Vis. Exp."},{"key":"1001_CR171","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yjmcc.2022.04.020","volume":"169","author":"G Cheng","year":"2022","unstructured":"Cheng, G., Zhu, D., Huang, K. & Caranasos, T. G. Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure. J. Mol. Cell Cardiol. 169, 113\u2013121 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR172","doi-asserted-by":"publisher","first-page":"eadd4623","DOI":"10.1126\/sciadv.add4623","volume":"9","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera, M. et al. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci. Adv. 9, eadd4623 (2023).","journal-title":"Sci. Adv."},{"key":"1001_CR173","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172\u2013176 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1001_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301929","volume":"10","author":"GS Naidu","year":"2023","unstructured":"Naidu, G. S. et al. A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery. Adv. Sci. 10, e2301929 (2023).","journal-title":"Adv. Sci."},{"key":"1001_CR175","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen, C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Deliv. Rev. 188, 114416 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1001_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"1001_CR177","doi-asserted-by":"publisher","first-page":"598175","DOI":"10.3389\/fphar.2020.598175","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge, X., Chen, L., Zhao, B. & Yuan, W. Rationale and application of PEGylated lipid-based system for advanced target delivery of siRNA. Front. Pharmacol. 11, 598175 (2020).","journal-title":"Front. Pharmacol."},{"key":"1001_CR178","doi-asserted-by":"publisher","first-page":"217365","DOI":"10.1155\/2014\/217365","volume":"2014","author":"I Scognamiglio","year":"2014","unstructured":"Scognamiglio, I. et al. Transferrin-conjugated SNALPs encapsulating 2\u2032-O-methylated miR-34a for the treatment of multiple myeloma. Biomed. Res. Int. 2014, 217365 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1001_CR179","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202201057","volume":"28","author":"J Lou","year":"2022","unstructured":"Lou, J. et al. Reactive oxygen species (ROS) activated liposomal cell delivery using a boronate-caged guanidine lipid. Chemistry 28, e202201057 (2022).","journal-title":"Chemistry"},{"key":"1001_CR180","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05350969 (2024)."},{"key":"1001_CR181","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03603431 (2019)."},{"key":"1001_CR182","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group.","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89\u201395 (2001).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1001_CR183","first-page":"100014","volume":"1","author":"C Schulte","year":"2022","unstructured":"Schulte, C. et al. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes. J. Mol. Cell Cardiol. 1, 100014 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR184","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","volume":"31","author":"Y D\u2019Alessandra","year":"2010","unstructured":"D\u2019Alessandra, Y. et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 31, 2765\u20132773 (2010).","journal-title":"Eur. Heart J."},{"key":"1001_CR185","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","volume":"384","author":"R Blanco-Dominguez","year":"2021","unstructured":"Blanco-Dominguez, R. et al. A novel circulating MicroRNA for the detection of acute myocarditis. N. Engl. J. Med. 384, 2014\u20132027 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1001_CR186","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41565-023-01479-z","volume":"18","author":"C Koch","year":"2023","unstructured":"Koch, C. et al. Nanopore sequencing of DNA-barcoded probes for highly multiplexed detection of microRNA, proteins and small biomarkers. Nat. Nanotechnol. 18, 1483\u20131491 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"1001_CR187","doi-asserted-by":"publisher","first-page":"117222","DOI":"10.1016\/j.cca.2023.117222","volume":"540","author":"H Almaghrbi","year":"2023","unstructured":"Almaghrbi, H., Giordo, R., Pintus, G. & Zayed, H. Non-coding RNAs as biomarkers of myocardial infarction. Clin. Chim. Acta 540, 117222 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"1001_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.05.011","volume":"70","author":"T Lalem","year":"2019","unstructured":"Lalem, T. & Devaux, Y. Circulating microRNAs to predict heart failure after acute myocardial infarction in women. Clin. Biochem. 70, 1\u20137 (2019).","journal-title":"Clin. Biochem."},{"key":"1001_CR189","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.omtn.2021.10.002","volume":"26","author":"ZJ Wen","year":"2021","unstructured":"Wen, Z. J. et al. Emerging roles of circRNAs in the pathological process of myocardial infarction. Mol. Ther. Nucleic Acids 26, 828\u2013848 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1001_CR190","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCGENETICS.113.000077","volume":"6","author":"Y Devaux","year":"2013","unstructured":"Devaux, Y. et al. MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circ. Cardiovasc. Genet. 6, 290\u2013298 (2013).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"1001_CR191","doi-asserted-by":"publisher","first-page":"439","DOI":"10.23736\/S2724-5683.20.05366-9","volume":"70","author":"D Scrutinio","year":"2022","unstructured":"Scrutinio, D., Conserva, F., Guida, P. & Passantino, A. Long-term prognostic potential of microRNA-150-5p in optimally treated heart failure patients with reduced ejection fraction: a pilot study. Minerva Cardiol. Angiol. 70, 439\u2013446 (2022).","journal-title":"Minerva Cardiol. Angiol."},{"key":"1001_CR192","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223606","volume":"14","author":"M Abu-Halima","year":"2019","unstructured":"Abu-Halima, M. et al. Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts. PLoS ONE 14, e0223606 (2019).","journal-title":"PLoS ONE"},{"key":"1001_CR193","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1536\/ihj.18-306","volume":"60","author":"X Lin","year":"2019","unstructured":"Lin, X., Zhang, S. & Huo, Z. Serum circulating miR-150 is a predictor of post-acute myocardial infarction heart failure. Int. Heart J. 60, 280\u2013286 (2019).","journal-title":"Int. Heart J."},{"key":"1001_CR194","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008686","volume":"15","author":"T Aonuma","year":"2022","unstructured":"Aonuma, T. et al. MiR-150 attenuates maladaptive cardiac remodeling mediated by long noncoding RNA MIAT and directly represses profibrotic Hoxa4. Circ. Heart Fail. 15, e008686 (2022).","journal-title":"Circ. Heart Fail."},{"key":"1001_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05982-y","volume":"14","author":"S Kawaguchi","year":"2023","unstructured":"Kawaguchi, S. et al. SPRR1A is a key downstream effector of MiR-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation. Cell Death Dis. 14, 446 (2023).","journal-title":"Cell Death Dis."},{"key":"1001_CR196","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150405","volume":"6","author":"T Aonuma","year":"2021","unstructured":"Aonuma, T. et al. Cardiomyocyte microRNA-150 confers cardiac protection and directly represses proapoptotic small proline-rich protein 1A. JCI Insight 6, e150405 (2021).","journal-title":"JCI Insight"},{"key":"1001_CR197","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/cvr\/cvv121","volume":"106","author":"Y Tang","year":"2015","unstructured":"Tang, Y. et al. MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death. Cardiovasc. Res. 106, 387\u2013397 (2015).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR198","doi-asserted-by":"publisher","first-page":"23586","DOI":"10.1074\/jbc.M113.489302","volume":"288","author":"J Li","year":"2013","unstructured":"Li, J. et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem. 288, 23586\u201323596 (2013).","journal-title":"J. Biol. Chem."},{"key":"1001_CR199","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1159\/000459899","volume":"41","author":"J Xiao","year":"2017","unstructured":"Xiao, J. et al. Circulating miR-30d predicts survival in patients with acute heart failure. Cell. Physiol. Biochem. 41, 865\u2013874 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"1001_CR200","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.114.013220","volume":"131","author":"YF Melman","year":"2015","unstructured":"Melman, Y. F. et al. Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study. Circulation 131, 2202\u20132216 (2015).","journal-title":"Circulation"},{"key":"1001_CR201","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2016.06.040","volume":"68","author":"M Vausort","year":"2016","unstructured":"Vausort, M. et al. Myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J. Am. Coll. Cardiol. 68, 1247\u20131248 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR202","first-page":"33","volume":"17","author":"A Salgado-Somoza","year":"2017","unstructured":"Salgado-Somoza, A., Zhang, L., Vausort, M. & Devaux, Y. The circular RNA MICRA for risk stratification after myocardial infarction. Int. J. Cardiol. Heart Vasc. 17, 33\u201336 (2017).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"1001_CR203","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/10635150490522304","volume":"53","author":"D Posada","year":"2004","unstructured":"Posada, D. & Buckley, T. R. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and Bayesian approaches over likelihood ratio tests. Syst. Biol. 53, 793\u2013808 (2004).","journal-title":"Syst. Biol."},{"key":"1001_CR204","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/cvr\/cvab094","volume":"117","author":"L Badimon","year":"2021","unstructured":"Badimon, L. et al. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovasc. Res. 117, 1823\u20131840 (2021).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13087","volume":"9","author":"H Firat","year":"2023","unstructured":"Firat, H. et al. FIMICS: a panel of long noncoding RNAs for cardiovascular conditions. Heliyon 9, e13087 (2023).","journal-title":"Heliyon"},{"key":"1001_CR206","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-023-00986-3","volume":"118","author":"M Sopic","year":"2023","unstructured":"Sopic, M. et al. Integration of epigenetic regulatory mechanisms in heart failure. Basic Res. Cardiol. 118, 16 (2023).","journal-title":"Basic Res. Cardiol."},{"key":"1001_CR207","first-page":"100013","volume":"1","author":"A Jusic","year":"2022","unstructured":"Jusic, A., Stellos, K., Ferreira, L., Baker, A. H. & Devaux, Y. (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19. J. Mol. Cell Cardiol. 1, 100013 (2022).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1001_CR208","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/cells11152271","volume":"11","author":"M Vausort","year":"2022","unstructured":"Vausort, M. et al. Regulation of N6-methyladenosine after myocardial infarction. Cells 11, 2271 (2022).","journal-title":"Cells"},{"key":"1001_CR209","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1093\/eurheartj\/ehab326","volume":"42","author":"EL Robinson","year":"2021","unstructured":"Robinson, E. L., Emanueli, C., Martelli, F. & Devaux, Y. Leveraging non-coding RNAs to fight cardiovascular disease: the EU-CardioRNA network. Eur. Heart J. 42, 4881\u20134883 (2021).","journal-title":"Eur. Heart J."},{"key":"1001_CR210","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.omtm.2021.12.007","volume":"24","author":"D de Gonzalo-Calvo","year":"2022","unstructured":"de Gonzalo-Calvo, D. et al. Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium. Mol. Ther. Methods Clin. Dev. 24, 171\u2013180 (2022).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1001_CR211","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.585","volume":"12","author":"D de Gonzalo-Calvo","year":"2022","unstructured":"de Gonzalo-Calvo, D., Perez-Boza, J., Curado, J., Devaux, Y. & EU-CardioRNA COST Action CA17129. Challenges of microRNA-based biomarkers in clinical application for cardiovascular diseases. Clin. Transl. Med. 12, e585 (2022).","journal-title":"Clin. Transl. Med."},{"key":"1001_CR212","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.molmed.2022.05.011","volume":"28","author":"D de Gonzalo-Calvo","year":"2022","unstructured":"de Gonzalo-Calvo, D., Sopic, M., Devaux, Y. & EU-CardioRNA COST Action CA17129. Methodological considerations for circulating long noncoding RNA quantification. Trends Mol. Med. 28, 616\u2013618 (2022).","journal-title":"Trends Mol. Med."},{"key":"1001_CR213","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10408363.2022.2128030","volume":"60","author":"P Lakkisto","year":"2023","unstructured":"Lakkisto, P. et al. Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done. Crit. Rev. Clin. Lab. Sci. 60, 141\u2013152 (2023).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"1001_CR214","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1093\/cvr\/cvab327","volume":"118","author":"M Vanhaverbeke","year":"2022","unstructured":"Vanhaverbeke, M. et al. Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129. Cardiovasc. Res. 118, 3183\u20133197 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR215","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrm2987","volume":"11","author":"A Schuldt","year":"2010","unstructured":"Schuldt, A. Great expectations of small RNAs. Nat. Rev. Mol. Cell Biol. 11, 676 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1001_CR216","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1065329","volume":"294","author":"RC Lee","year":"2001","unstructured":"Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862\u2013864 (2001).","journal-title":"Science"},{"key":"1001_CR217","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35040556","volume":"408","author":"AE Pasquinelli","year":"2000","unstructured":"Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86\u201389 (2000).","journal-title":"Nature"},{"key":"1001_CR218","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum, T. et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116, 258\u2013267 (2007).","journal-title":"Circulation"},{"key":"1001_CR219","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCRESAHA.111.244442","volume":"110","author":"TG Hullinger","year":"2012","unstructured":"Hullinger, T. G. et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 110, 71\u201381 (2012).","journal-title":"Circ. Res."},{"key":"1001_CR220","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1073\/pnas.1208863110","volume":"110","author":"ER Porrello","year":"2013","unstructured":"Porrello, E. R. et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl Acad. Sci. USA 110, 187\u2013192 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1001_CR221","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","volume":"143","author":"D Ramanujam","year":"2021","unstructured":"Ramanujam, D. et al. MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload. Circulation 143, 1513\u20131525 (2021).","journal-title":"Circulation"},{"key":"1001_CR222","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1172\/JCI123135","volume":"129","author":"L Qiao","year":"2019","unstructured":"Qiao, L. et al. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J. Clin. Invest. 129, 2237\u20132250 (2019).","journal-title":"J. Clin. Invest."},{"key":"1001_CR223","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","volume":"75","author":"R Hinkel","year":"2020","unstructured":"Hinkel, R. et al. AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury. J. Am. Coll. Cardiol. 75, 1788\u20131800 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1001_CR224","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.118.312420","volume":"122","author":"J Mayourian","year":"2018","unstructured":"Mayourian, J. et al. Exosomal microRNA-21-5p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ. Res. 122, 933\u2013944 (2018).","journal-title":"Circ. Res."},{"key":"1001_CR225","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ejhf.1119","volume":"20","author":"S De Rosa","year":"2018","unstructured":"De Rosa, S. et al. Transcoronary concentration gradients of circulating microRNAs in heart failure. Eur. J. Heart Fail. 20, 1000\u20131010 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"1001_CR226","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/ehf2.13371","volume":"8","author":"A Galluzzo","year":"2021","unstructured":"Galluzzo, A. et al. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. Esc. Heart Fail. 8, 2907\u20132919 (2021).","journal-title":"Esc. Heart Fail."},{"key":"1001_CR227","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cvr\/cvu254","volume":"105","author":"M Yan","year":"2015","unstructured":"Yan, M. et al. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovasc. Res. 105, 340\u2013352 (2015).","journal-title":"Cardiovasc. Res."},{"key":"1001_CR228","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/cells12192369","volume":"12","author":"E Boxhammer","year":"2023","unstructured":"Boxhammer, E. et al. MicroRNA-30d-5p-A potential new therapeutic target for prevention of ischemic cardiomyopathy after myocardial infarction. Cells 12, 2369 (2023).","journal-title":"Cells"},{"key":"1001_CR229","doi-asserted-by":"publisher","first-page":"104108","DOI":"10.1016\/j.ebiom.2022.104108","volume":"81","author":"J Li","year":"2022","unstructured":"Li, J. et al. Targeting miR-30d reverses pathological cardiac hypertrophy. EBioMedicine 81, 104108 (2022).","journal-title":"EBioMedicine"},{"key":"1001_CR230","doi-asserted-by":"publisher","first-page":"784044","DOI":"10.3389\/fcvm.2021.784044","volume":"8","author":"CC Hua","year":"2021","unstructured":"Hua, C. C., Liu, X. M., Liang, L. R., Wang, L. F. & Zhong, J. C. Targeting the microRNA-34a as a novel therapeutic strategy for cardiovascular diseases. Front. Cardiovasc. Med. 8, 784044 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1001_CR231","doi-asserted-by":"publisher","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","volume":"309","author":"S Matsushima","year":"2015","unstructured":"Matsushima, S. & Sadoshima, J. The role of sirtuins in cardiac disease. Am. J. Physiol. Heart Circ. Physiol. 309, H1375\u2013H1389 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1001_CR232","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1113\/JP270557","volume":"594","author":"T Seeger","year":"2016","unstructured":"Seeger, T. & Boon, R. A. MicroRNAs in cardiovascular ageing. J. Physiol. 594, 2085\u20132094 (2016).","journal-title":"J. Physiol."},{"key":"1001_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12192-y","volume":"7","author":"JN Zhu","year":"2017","unstructured":"Zhu, J. N. et al. Activation of miR-34a-5p\/Sirt1\/p66shc pathway contributes to doxorubicin-induced cardiotoxicity. Sci. Rep. 7, 11879 (2017).","journal-title":"Sci. Rep."},{"key":"1001_CR234","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.118.034598","volume":"138","author":"EM Rogg","year":"2018","unstructured":"Rogg, E. M. et al. Analysis of cell type-specific effects of microRNA-92a provides novel insights into target regulation and mechanism of action. Circulation 138, 2545\u20132558 (2018).","journal-title":"Circulation"},{"key":"1001_CR235","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-0716-3346-5_19","volume":"2695","author":"W Zhu","year":"2023","unstructured":"Zhu, W. & Li, X. Liquid biopsy in coronary heart disease. Methods Mol. Biol. 2695, 279\u2013293 (2023).","journal-title":"Methods Mol. Biol."},{"key":"1001_CR236","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1161\/CIRCULATIONAHA.112.093906","volume":"126","author":"P Jakob","year":"2012","unstructured":"Jakob, P. et al. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 126, 2962\u20132975 (2012).","journal-title":"Circulation"},{"key":"1001_CR237","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki, A. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810\u2013817 (2010).","journal-title":"Circ. Res."},{"key":"1001_CR238","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich, S. J. et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 106, 166\u2013175 (2010).","journal-title":"Circ. Res."},{"key":"1001_CR239","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1161\/CIRCULATIONAHA.109.928424","volume":"122","author":"S Hu","year":"2010","unstructured":"Hu, S. et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122, S124\u2013S131 (2010).","journal-title":"Circulation"},{"key":"1001_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03713-9","volume":"12","author":"G Zaccagnini","year":"2021","unstructured":"Zaccagnini, G. et al. Hypoxia-induced miR-210 modulates the inflammatory response and fibrosis upon acute ischemia. Cell Death Dis. 12, 435 (2021).","journal-title":"Cell Death Dis."},{"key":"1001_CR241","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15252\/emmm.201606924","volume":"9","author":"L Cambier","year":"2017","unstructured":"Cambier, L. et al. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion. EMBO Mol. Med. 9, 337\u2013352 (2017).","journal-title":"EMBO Mol. Med."},{"key":"1001_CR242","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1042\/CS20210994","volume":"136","author":"D Busscher","year":"2022","unstructured":"Busscher, D., Boon, R. A. & Juni, R. P. The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases. Clin. Sci. 136, 1157\u20131178 (2022).","journal-title":"Clin. Sci."},{"key":"1001_CR243","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/mt.2016.41","volume":"24","author":"M Boulberdaa","year":"2016","unstructured":"Boulberdaa, M. et al. A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol. Ther. 24, 978\u2013990 (2016).","journal-title":"Mol. Ther."},{"key":"1001_CR244","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt, D. L., Lopes, R. D. & Harrington, R. A. Diagnosis and treatment of acute coronary syndromes: a review. JAMA 327, 662\u2013675 (2022).","journal-title":"JAMA"},{"key":"1001_CR245","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013361","volume":"8","author":"D Mukherjee","year":"2019","unstructured":"Mukherjee, D. Myocardial infarction with nonobstructive coronary arteries: a call for individualized treatment. J. Am. Heart Assoc. 8, e013361 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"1001_CR246","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne, R. A. et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur. Heart J. 44, 3720\u20133826 (2023).","journal-title":"Eur. Heart J."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01001-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01001-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01001-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T13:16:46Z","timestamp":1721308606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01001-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":246,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1038\/s41569-024-01001-5","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"19 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. is a co-founder of MIRAVA Therapeutics. Y.D. holds patents and licensing agreements related to the use of RNAs for diagnostic and therapeutic purposes and is a member of the Scientific Advisory Board of the molecular diagnostics company Firalis SA. T.P. is a co-founder of Haya Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}